September 2026
Know What’s New With Flu Vaccines for 2026-2027
Your team will be the first place patients turn with questions about this season’s flu shot. Our articles walk through what’s new for 2026-2027, including when to preferentially reach for a higher-dose or adjuvanted vaccine in patients 65 and older, and how to counsel on mFlusiva, the first mRNA-based flu vaccine now approved for patients 50 and up (more side effects, and payer coverage may vary). We also cover the ideal timing for vaccination, how to discuss flu effectiveness, and which other vaccines can be given at the same visit. Your team can use our Flu Vaccines for 2026-27 chart to sort through products, and our Communicating About Flu Vaccination resource for answers to common patient questions.
Read More:
Community Pharmacies: Enlicitide (Lipfendra): The First Oral PCSK9 Inhibitor for Cholesterol
You’ll hear that enlicitide (Lipfendra) is a gamechanger for managing high cholesterol…as the first oral PCSK9 inhibitor. Our articles cover how enlicitide 20 mg once daily lowers LDL-C by about 60% when added to a statin, similar to injectable PCSK9 inhibitors, but without CV outcomes data yet. We also outline when to consider a PCSK9 inhibitor over ezetimibe, key administration requirements patients need to know (taken on an empty stomach, kept in its original container), and how enlicitide compares on cost to other non-statin options. Your team can reach for our Non-Statin Lipid-Lowering Agents chart to see how PCSK9 inhibitors compare to other options, including bempedoic acid and ezetimibe.
Read More:
Hospitals: Prevent Mishaps Involving Unusual Dosing Schedules
Hospital teams should be ready to catch errors involving meds with out-of-the-ordinary dosing schedules—especially after FDA’s recent boxed warning for methotrexate about fatal errors when weekly doses were accidentally given daily. Our articles review meds prone to this kind of mix-up (weekly patches, alternating-dose regimens, meds with different frequencies by dosage form) and outlines practical safeguards: confirming the timing of a patient’s last outpatient dose on admission, building hard stops or high-dose flags into your EHR, and naming a specific day (“every Friday”) in discharge directions for weekly meds. Teams can turn to our Responding to Med Errors checklist for more guidance on protecting patients and reducing error risk.
Read More:
Patients see fish oil as a “heart-healthy” supplement, but many don’t realize high doses carry a real risk of atrial fibrillation (AF). Our NatMed article covers the evidence. AF risk is dose-dependent, rising sharply above 1 gram daily and highest at 4 grams daily. Fish oil can also raise LDL levels. Patients on higher doses, especially those with cardiovascular risk factors, should have both AF symptoms and LDL monitored.
Patients see fish oil as a “heart-healthy” supplement, but many don’t realize high doses carry a real risk of atrial fibrillation (AF). Our NatMed article covers the evidence. AF risk is dose-dependent, rising sharply above 1 gram daily and highest at 4 grams daily. Fish oil can also raise LDL levels. Patients on higher doses, especially those with cardiovascular risk factors, should have both AF symptoms and LDL monitored.
In our latest episode, ADHD Supplement Stacking: Are More Supplements Better?, NatMed editors Jeff Langford, Andrea Stafford, and Kelly Daniels break down what ADHD supplement stacking is, which ingredients are showing up most often, what the clinical evidence shows, and where the real safety concerns lie.
We're excited to share that we've launched a new Content Updates page on NatMed Pro that provides a real-time log of monographs recently reviewed and updated by our editorial team. Covering the past three months of updates, the page shows exactly which sections have changed—including Effectiveness, Safety, Adverse Effects, Drug Interactions, Dosing, and more—so you can quickly see what's new without digging through individual monographs.
Listen to this month’s podcast episode, Decoding the Lipid Guidelines, as our expert panel breaks down what clinicians need to know about the 2026 dyslipidemia guidelines, such as the role of lipoprotein a, apolipoprotein B, and coronary artery calcium scoring. Plus, you’ll walk away with practical takeaways to optimize lipid management including when to add non-statin therapies like PCSK9 inhibitors and ezetimibe for your patients.
All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to the latest episode, Opioids, as our editors separate opioid fact from folklore by challenging long-held assumptions with the latest evidence.
All Rumor vs Truth podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to our latest episode, Artificial Intelligence (AI) in Pharmacy: Practical Dos and Don’ts, as our Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how AI can support healthcare teams while emphasizing the continued importance of clinical judgment, verification, and patient-specific care. Learn practical strategies for using AI safely in your practice, what risks to watch for, and how to guide patients when it comes to AI-generated health information.
All Clinical Capsules podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Dates: September 15, 17 & 19
In this month's live webinar, Weight No More: Navigating Obesity Treatment, our panelists discuss evidence-based approaches to obesity pharmacotherapy—including how to select among available agents, set realistic expectations with patients, and manage therapy long term. They’ll also address practical strategies for navigating cost and payer coverage.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
Upcoming 2026 Live Webinars
Save the date for our “Super Saturday” event on September 19 to earn up to 4 hours of live CE! Register now in your CE & Training Organizer for these Pharmacy Essential Updates sessions.
Also, Check out our upcoming Pharmacy Essential live CE webinars.
Dates: September 9, 10, 19, 22, and 24
Topics for September include:
*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.
GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Use our customizable chart to compare options and get guidance on switches.
Antivirals for Influenza
Compare treatment options and get guidance on who to treat and when.
Pharmacotherapy of Neuropathic Pain
Get guidance on choosing and dosing meds for neuropathic pain.
Managing Beta-Lactam Allergies
Help patients and prescribers navigate beta-lactam allergies and cross-reactivity.
Comparison of Insulins
Compare available insulin products to support product selection and switches.
Most health systems run into the same roadblocks: inconsistent onboarding across departments, competency assessments that live in spreadsheets or binders, training records scattered across multiple EMRs or LMS platforms, and no clear, real-time view of who's actually ready for the next survey.
The Compounding Compliance Suite was built to close those gaps — giving hospital pharmacy leaders a comprehensive set of training, assessment, and documentation resources to standardize practice and support survey readiness.
With the Suite, you can:
Built on CriticalPoint's trusted, USP-focused education and used by leading health systems nationwide, the Compounding Compliance Suite helps hospital pharmacy teams move from reactive fixes to continuous, provable readiness.
We’re excited to have partnered with Becker’s Healthcare for this webinar featuring our Chief Pharmacy Officer, Dr. Tina Moen, PharmD, and Michael Alexander, Co-Founder at Audirie.
In this recorded session, Tina and Michael explore what traditional training models may miss about whether teams are ready to perform when a situation demands more than process knowledge.
The conversation examines why traditional models were built to move people through a process rather than surface how they respond under real pressure, and what a modern performance validation strategy can make possible across multiple sites and shifting workforce demands.
Please note: This webinar is intended for educational and informational purposes only and does NOT offer CE/CME credit.
Recent federal action on childhood vaccines has moved several vaccines that were previously recommended for all children into a "shared clinical decision-making" category. We've put together a resource to help your teams navigate conversations with patients and families as these recommendations evolve.
Childhood Vaccine Executive Order: Your Questions Answered covers what the order does and doesn't change, what "shared clinical decision-making" means for your recommendations, and how to respond to the questions parents are most likely to bring to you.